Levels of activated pAKT and pERK1/2 in breast tumors would be determined by two main mechanisms: signaling from the ERBB2 oncoprotein itself, and signaling from other receptors and pathways normally present in the cell. Here, ERBB2 is linked to breast neoplasm.